RopesTalk

This episode of Ropes & Gray’s podcast series Non-binding Guidance examines FDA’s final guidance on Clinical Decision Support (“CDS”) software, released in September, and its implications for the life sciences and health care industries. The final guidance represents a substantial change in FDA’s approach to CDS software regulation from the agency’s 2019 draft guidance and may prompt many software developers to reassess their CDS products in light of the new guidance. Join Ropes & Gray FDA regulatory partners Greg Levine and Kellie Combs and counsel Sarah Blankstein as they discuss FDA’s new CDS guidance and provide an overview of key changes, practical implications, and some of the challenges posed by the guidance.

In this episode of Women @ RopesTalk, Ropes & Gray health care partners Jenn Romig and Christina Bergeron interview Lisa Mango, chief legal officer and general counsel of One Medical, a human-centered, technology-powered U.S. primary care organization on a mission to make quality health care more affordable, accessible, and enjoyable through a seamless combination of in-person, digital, and virtual care services. Lisa talks about the evolution of her career, beginning at a mid-sized law firm and then moving to in-house legal roles at early dot-com and design software companies before starting at One Medical in 2016. In looking back at her career, Lisa encourages junior lawyers to embrace the unknown, reflects on an important mentor, and shares her approach to working and parenting. Finally, she talks about the exciting past few years at One Medical, including the company’s recent agreement with Amazon.

In this Ropes & Gray podcast, partners Ama Adams and Brendan Hanifin, counsel Emerson Siegle, and associate Kurt Fowler discuss FinCEN rulemaking implementing the beneficial ownership reporting requirements of the Corporate Transparency Act. The rule will significantly expand the scope of information that certain legal entities must disclose under U.S. law, and compliance with the rule’s requirements may present particular complexity for traditional tiered holding company structures.

In this Ropes & Gray podcast, health care partner Stephanie Webster and litigation & enforcement partner Jane Willis discuss recent rulemakings by the Centers for Medicare and Medicaid Services (“CMS”) regarding Competition and Transparency in health care. They address how this rule is part of a broader effort by the Biden Administration to aggressively enforce the antitrust laws, and in particular, what hospitals, health care systems, and other health care providers might expect from this rulemaking and the broader trend it signals.

In this episode of the R&G Tech Studio, venture capital & emerging companies co-lead Brad Flint sits down with technology, media & telecommunications co-lead Ed Black to discuss his practice and to share his thoughts on the evolving tech and regulatory landscape impacting the venture community.

Following the first action filed by a U.S. federal regulator against a DAO and its members, asset management attorneys Melissa Bender, Jeremy Liabo and Glen Chen discuss the Ooki DAO case and its implications on the potential liability of DAO token holders, DAO legal wrappers and the CFTC’s role in regulating digital assets.

The Ropes & Gray Decoding Digital Health podcast series discusses the digital health industry and related legal, business and regulatory issues. On this episode, Digital Health Initiative co-lead and IP transactions partner, Megan Baca, is joined by Verily Life Sciences Lead Product Counsel, John Vaughan, to continue their discussion on Verily’s innovative partnerships in digital health, the challenges Verily has faced as well as the rewarding solutions that Verily and its partnerships have created.

Welcome to the R&G Tech Studio, a Ropes & Gray podcast series highlighting the firm’s technology attorneys, their respective practice areas and how the ever-changing tech landscape impacts their clients. On this inaugural episode, private equity partner Scott Abramowitz sits down to discuss his practice and how the fintech industry has evolved with TMT co-lead Ed Black.

The Ropes & Gray Decoding Digital Health podcast series discusses the digital health industry and related legal, business and regulatory issues. On this episode, Digital Health Initiative co-lead and IP transactions partner, Megan Baca, is joined by Verily Life Sciences Lead Product Counsel, John Vaughan, for a two-part discussion on digital health dealmaking. Megan and John dive into topics related to partnership strategies between biopharma and tech companies, as well as the key opportunities and challenges associated with digital health innovation deals.

In this Ropes & Gray podcast, finance partner Alyson Gal and counsel Patricia Teixeira discuss the use of credit facilities as an important source of liquidity and leverage for registered investment funds. They explore the regulatory landscape applicable to these facilities and review some of their key terms.